Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use
Medical care for patients hospitalized with COVID-19 is an evolving process. Most COVID-19 inpatients (58–95%) received empiric antibiotics to prevent the increased mortality due to ventilator-associated pneumonia and other secondary infections observed in COVID-19 patients. The expected consequence...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2021-04-01
|
| Col·lecció: | Antibiotics |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2079-6382/10/4/408 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|